4//SEC Filing
Zankel Todd 4
Accession 0001140361-12-039191
CIK 0001070698other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 3:45 PM ET
Size
12.2 KB
Accession
0001140361-12-039191
Insider Transaction Report
Form 4
Zankel Todd
Chief Scientific Officer
Transactions
- Sale
Common Stock
2012-08-31$5.00/sh−3,858$19,290→ 652,708 total - Exercise/Conversion
Stock options (right to buy)
2012-08-31−3,642→ 308,921 totalExercise: $2.83From: 2006-11-25Exp: 2016-05-25→ Common Stock (3,642 underlying) - Sale
Common Stock
2012-08-31$5.00/sh−3,642$18,210→ 656,566 total - Sale
Common Stock
2012-08-30$5.00/sh−2,648$13,240→ 656,566 total - Exercise/Conversion
Common Stock
2012-08-31$2.83/sh+3,642$10,307→ 660,208 total
Footnotes (3)
- [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
- [F2]Original option grant vests 6/36ths on November 25, 2006 and 1/36th per month thereafter.
- [F3]This transaction was executed in multiple trades at prices ranging from $5.00 to $5.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Raptor Pharmaceutical Corp
CIK 0001070698
Entity typeother
Related Parties
1- filerCIK 0001362490
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 3:45 PM ET
- Size
- 12.2 KB